Bardoxolone (Standard)
Bardoxolone (Standard) is the analytical standard of Bardoxolone (HY-14909). This product is intended for research and analytical applications. Bardoxolone is an orally active activator of nuclear regulatory factor (NRf-2) and an inhibitor of SARS-CoV-2 3CL protease. Bardoxolone inhibits SARS-CoV-2 3CL protease with an EC50 value of 0.43 μM in vero cells. Bardoxolone also inhibits necroptosis in HT-29 cells with an EC50 value of 1.30 μM by blocking necrosome formation through inhibiting phosphorylation of RIPK1 and RIPK3. Bardoxolone can be used in research on COVID-19, TNF-induced systemic inflammatory response syndrome (SIRS), and cerebral ischemia-reperfusion injury.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98%
- No. CAS: 218600-44-3
- Fòrmula: C31H41NO4
- Peso molecular:491.66
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-14909
BardoxoloneNrf2 Activator -
HY-17363
Dimethyl fumarateNrf2 Activator -
HY-13755
SulforaphaneKeap1/Nrf2/ARE Inducer -
HY-12212
OmaveloxoloneNrf2 Activator -
HY-112675
4-Octyl itaconateNrf2 Activator -
HY-13324
Bardoxolone methylNrf2 Activator -
HY-19734
NK-252Nrf2 Activator -
HY-N0290
MangiferinNrf2 Activator -
HY-100523
ML385Nrf2 Inhibitor -
HY-18738
Pyrrolidinedithiocarbamate ammoniumSelective NF-κB Inhibitor -
HY-13982
JSH-23NF-κB Inhibitor -
HY-17363R
Dimethyl fumarate (Standard)Nrf2 Activator
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 218600-44-3
-
Peso molecular 491.66
-
Fòrmula C31H41NO4
-
SMILES
CC1(C)CC[C@@]2(C(O)=O)[C@@]([C@](C(C=C3[C@@]4(C)CC[C@]5([H])[C@]3(C)C=C(C#N)C(C5(C)C)=O)=O)([H])[C@@]4(C)CC2)([H])C1
-
Synonyms
CDDO (Standard); RTA 401 (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Sun Q, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 May 29;6(1):212. [Content Brief]
[2]. Wang Y, et al. Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors. Eur J Med Chem. 2021 Feb 15;212:113030. [Content Brief]
[4]. Kim HK, et al. Bardoxolone Methyl Ameliorates Chemotherapy-Induced Neuropathic Pain by Activation of Phosphorylated Nuclear Factor Erythroid 2-Related Factor 2 in the Dorsal Root Ganglia. Anesth Analg. 2024 Mar 1;138(3):664-675. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Bardoxolone (Standard) Related Classifications
HY-14909R Related Classifications
Powered by Bioz
Keywords
- Bardoxolone (Standard)
- 218600-44-3
- CDDO (Standard)
- RTA 401 (Standard)
- Keap1-Nrf2
- Necroptosis
- SARS-CoV
- Virus Protease
- Reference Standards
- chronic kidney disease
- HT-29 cells
- necroptosis
- Nrf2 activator
- antioxidant system
- inflammatory cytokines
- apoptosis
- rat kidney
- mitochondrial damage
- analgesic effect
- neuropathic pain
- Inhibitor
- inhibitor
- inhibit